Current Ratio in % of Nurix Therapeutics, Inc. from Q2 2021 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Nurix Therapeutics, Inc. quarterly Current Ratio history and change rate from Q2 2021 to Q3 2025.
  • Nurix Therapeutics, Inc. Current Ratio for the quarter ending 31 Aug 2025 was 622 %, a 46.3% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Nurix Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 622 +197 +46.3% 31 Aug 2025
Q2 2025 620 +220 +55.2% 31 May 2025
Q1 2025 592 +234 +65.3% 28 Feb 2025
Q4 2024 507 +107 +26.8% 30 Nov 2024
Q3 2024 425 -7.32 -1.69% 31 Aug 2024
Q2 2024 399 -55.5 -12.2% 31 May 2024
Q1 2024 358 -102 -22.1% 29 Feb 2024
Q4 2023 400 -55.5 -12.2% 30 Nov 2023
Q3 2023 433 -27.4 -5.96% 31 Aug 2023
Q2 2023 455 -37 -7.52% 31 May 2023
Q1 2023 460 -126 -21.5% 28 Feb 2023
Q4 2022 455 -195 -30% 30 Nov 2022
Q3 2022 460 -258 -35.9% 31 Aug 2022
Q2 2022 492 -268 -35.3% 31 May 2022
Q1 2022 586 28 Feb 2022
Q4 2021 650 30 Nov 2021
Q3 2021 718 31 Aug 2021
Q2 2021 759 31 May 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.